Efficacy and Tolerability of Tasipimidine in Sleepless Patients
Clinical trial NCT06956495 · COMPLETED
Trial details
- NCT number
- NCT06956495
- Sponsor
- Orion Corporation, Orion Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-20
- Primary completion
- 2025-09-11
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.